Navigation Links
Enobia Announces Positive Clinical Results With ENB-0040, a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia
Date:9/14/2009

tudy have opted to continue treatment under a long-term extension protocol, and we have amended the initial study to include an additional five patients. We will also begin enrollment of a Phase 2 study in children aged five to 12 years in the weeks ahead."

Study Design and Findings

The infant study was designed to assess the safety, tolerability and efficacy of ENB-0040 in infants with HPP. Subjects received an initial intravenous dose of ENB-0040, followed by subcutaneous injections three times weekly for six months.

Three severely affected infants and two young children completed six months of treatment. There were no deaths or drug-related serious adverse events. Subcutaneous dosing was well tolerated, and no anti-ENB-0040 antibodies were detected. At six months, four of five patients with severe rickets treated with ENB-0040 showed marked radiographic, respiratory and functional improvement, while the fifth and most severely affected showed functional improvement and changes in biochemical markers suggesting bone remineralization. Notably, no new fractures were reported.

About Hypophosphatasia

Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease. Affected individuals have low levels of the tissue non-specific form of alkaline phosphatase, an essential regulator of bone mineralization, leading to rickets in infants and children and osteomalacia ("soft bones" resulting from poor mineralization) in adults. Disease severity is inversely proportional to the age at symptom onset. Clinical severity ranges from the severe perinatal or infantile forms, with marked skeletal hypomineralization and respiratory compromise often causing death, to a persistent and debilitating osteomalacia in adults.

In the infantile form, infants may appear normal at birth but develop serious symptoms in the first six months of life. These can include failur
'/>"/>

SOURCE Enobia Pharma Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease
2. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
3. Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
4. Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
5. Artielle ImmunoTherapeutics Announces Positive Results of Phase 1 Multiple Sclerosis Trial
6. Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
7. Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
8. Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV
9. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
10. ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
11. BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 1, 2015 Ansell, a global ... winners of the first Ansell Cares ® ... Nurses. The 2015 award, organised in partnership with the ... who display exceptional skill and quality in patient care, ... development. Award ceremonies are taking place today in the ...
(Date:6/30/2015)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a ... today announced it has submitted its fifth abbreviated new ... Administration (FDA) of 2015, which brings the Company,s total ... to twenty-seven. Jason Grenfell-Gardner , President ... current pipeline of twenty-seven submissions, exclusive of our four ...
(Date:6/30/2015)... , June 30, 2015  A new report ... a campaign to promote public education and training opportunities ... and defibrillation. Annual rates of CPR ... percent in the United States ... cardiac arrest survival. The American Red Cross strongly supports ...
Breaking Medicine Technology:Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 2New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 3New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 4
... Carl Zeiss Group is adopting AT&T ... suppliers and subsidiaries around the world, across three continents. ... leader in the optical and optoelectronics industry with around ... countries Carl Zeiss will connect sites in Germany ...
... Health care costs are increasing, but NeedyMeds.org ... save money while staying healthy. NeedyMeds.org is ... discounts on prescription medications and other medical needs.  Consumer ... both English and Spanish regarding cost savings on prescription ...
Cached Medicine Technology:AT&T Helps Make The World a Smaller Place for Carl Zeiss 2AT&T Helps Make The World a Smaller Place for Carl Zeiss 3AT&T Helps Make The World a Smaller Place for Carl Zeiss 4Non-Profit Offers 3 Easy Consumer Tips to Save on Prescriptions 2
(Date:6/30/2015)... ... June 30, 2015 , ... The LIV Fertility Center in Puerto Vallarta ... the right age to pursue egg freezing. Statistics show that 20 percent of women ... a 150 percent increase since the 1970s. , Sadly, for women who have delayed ...
(Date:6/30/2015)... Grand Terrace, CA (PRWEB) , ... June 30, ... ... its Five-Star Medicare rating in a new video, “Grand Terrace Health Care Center.” ... keep facilities accountable and help patients find the best facility for their needs. ...
(Date:6/30/2015)... Port Richey, FL (PRWEB) , ... June 30, 2015 , ... ... use nearly doubled from 2007 to 2013 while heroin-related deaths more than tripled in ... greatest drug threat (1). Novus Medical Detox Center , a leading Florida-based drug ...
(Date:6/30/2015)... ... 2015 , ... ADVOCATE, the premier provider of radiology revenue ... billing agreements with Jackson Radiology Associates in Jackson, TN. , ADVOCATE ... billing process software functionality called Experience Based Technology (EBTTM). EBTTM improves radiology ...
(Date:6/30/2015)... ... June 30, 2015 , ... On June 26, 2015, Harper’s Bazaar ... five triggers that most people would not expect to cause acne flare-ups. ... primary causes of acne are clogged pores and bacteria and each of ...
Breaking Medicine News(10 mins):Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Grand Terrace Health Care Center Announces Five-Star Rating in YouTube Video 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2
... , 70 Years of Service Excellence and Innovation Leads ... to Improve Patient Care and Increase Productivity , ... interoperability of disparate healthcare IT systems, announced today that ... Radiology Associates of the Fox Valley (RAFV) of Neenah, ...
... , CARLSBAD, Calif., June 5 Isis Pharmaceuticals, Inc. (Nasdaq: ... management will present a company overview at the 8th Annual Needham ... ET at the New York Palace Hotel. , ... on the "Investor Center" section of the Company,s Web site, ...
... ... London Clinic. The contract marks the world,s first live site of the company,s latest Rhapsody™ ... Auckland, ... workflow and integration technology for the health care sector world-wide, has signed a contract with ...
... ... to his distinguished career as attorney in Maryland , ... Columbia, Maryland (Lexis Nexis) -- Bruce Plaxen, founding ... as the 2008 Maryland Trial Lawyer of the Year by the non-profit Maryland Association ...
... They Would During Any Flu Outbreak , , HARRISBURG, Pa., ... Novel Influenza A/H1N1 was reported today in Berks County. Currently, the ... due to this virus. Nationally, there are 11,054 confirmed cases of ... this 55-year-old woman is a sad reminder of the complications that ...
... June 4 Today, in Los Angeles, Univision, People en Espanol, ... to the Latino community as la Doctora Aliza (TM), announced ... (TM). , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090604/SF28145 ) ... the largest source of health information and wellness tools in Spanish ...
Cached Medicine News:Health News:Compressus Initiates Enterprise Workflow Management Implementation at Radiology Associates of Fox Valley 2Health News:Compressus Initiates Enterprise Workflow Management Implementation at Radiology Associates of Fox Valley 3Health News:Orion Health Live at Harley Street Clinic 2Health News:Orion Health Live at Harley Street Clinic 3Health News:Bruce Plaxen Named 2008 Maryland Trial Lawyer of the Year by Maryland Association for Justice 2Health News:Health Department Reports Pennsylvania's First Death Due to 2009 Novel Influenza A/H1N1 Virus 2Health News:Univision's Doctora Aliza Launches VidaySalud.com(TM) 2
... a new level of immunodiagnostic productivity. Optimal ... any laboratory automation system. No-pause loading of ... the only immunoassay system with this capability. ... runs without any additional setup. Continuous sample ...
... Engineered for small and medium volume laboratories, ... 1010 System offers the speed, simplicity and ... requirements. Compact yet powerful, the Elecsys 1010 ... rapid response assays to routine testing without ...
... Behring's Dimension clinical chemistry integrated systems combine ... reagent cartridge, the power of the Multiply ... of the heterogeneous module to meet the ... and broad test menus, the systems can ...
The Embla 96/384 well washer is a top-loading, robotic-compatible plate washer for 96- and 384-well microplate washing. It is ideal for ELISAs and most cell applications....
Medicine Products: